Synergistic in-vitro antiviral effects of combination treatment using anidulafungin and T-1105 against Zika virus infection

Barrows, 2016, A screen of FDA-approved drugs for inhibitors of zika virus infection, Cell Host Microbe, 20, 259, 10.1016/j.chom.2016.07.004 Cai, 2017, Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication, Arch. Virol., 162, 2847, 10.1007/s00705-017-3436-8 Campos, 2015, Zika virus outbreak, bahia, Brazil, Emerg. Infect. Dis., 21, 1885, 10.3201/eid2110.150847 Chen, 2021, Micafungin inhibits dengue virus infection through the disruption of virus binding, entry, and stability, Pharmaceuticals, 14, 10.3390/ph14040338 Chou, 1984, Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors, Adv. Enzym. Regul., 22, 27, 10.1016/0065-2571(84)90007-4 De Burghgraeve, 2012, An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro, PLoS One, 7, 10.1371/journal.pone.0037244 Dick, 1952, Zika virus. I. Isolations and serological specificity, Trans. R. Soc. Trop. Med. Hyg., 46, 509, 10.1016/0035-9203(52)90042-4 Duffy, 2009, Zika virus outbreak on yap island, Federated States OF Micronesia, N. Engl. J. Med., 360, 2536, 10.1056/NEJMoa0805715 Enfissi, 2016, Zika virus genome from the Americas, Lancet, 387, 227, 10.1016/S0140-6736(16)00003-9 Ho, 2018, Micafungin is a novel anti-viral agent of chikungunya virus through multiple mechanisms, Antivir. Res., 159, 134, 10.1016/j.antiviral.2018.10.005 Ho, 2019, Palmatine inhibits Zika virus infection by disrupting virus binding, entry, and stability, Biochem. Biophys. Res. Commun., 518, 732, 10.1016/j.bbrc.2019.08.120 Ho, 2015, Suramin inhibits chikungunya virus entry and transmission, PLoS One, 10, 10.1371/journal.pone.0133511 Huang, 2019, Isobologram analysis: a comprehensive review of methodology and current research, Front. Pharmacol., 10, 1222, 10.3389/fphar.2019.01222 Jeon, 2020, Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs, Antimicrob. Agents Chemother., 64, 10.1128/AAC.00819-20 Kim, 2016, Antiviral activity of micafungin against enterovirus 71, Virol. J., 13, 99, 10.1186/s12985-016-0557-8 Kuno, 1998, Phylogeny of the genus flavivirus, J. Virol., 72, 73, 10.1128/JVI.72.1.73-83.1998 Lai, 2020, Cephalotaxine inhibits Zika infection by impeding viral replication and stability, Biochem. Biophys. Res. Commun., 522, 1052, 10.1016/j.bbrc.2019.12.012 Lai, 2020, Harringtonine inhibits zika virus infection through multiple mechanisms, Molecules, 25, 10.3390/molecules25184082 Leonhard, 2019, Diagnosis and management of Guillain-Barre syndrome in ten steps, Nat. Rev. Neurol., 15, 671, 10.1038/s41582-019-0250-9 Lessler, 2016, Assessing the global threat from Zika virus, Science, 353, aaf8160, 10.1126/science.aaf8160 Lu, 2017, Synergistic effects of combination treatment using EGCG and suramin against the chikungunya virus, Biochem. Biophys. Res. Commun., 491, 595, 10.1016/j.bbrc.2017.07.157 Macnamara, 1954, Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria, Trans. R. Soc. Trop. Med. Hyg., 48, 139, 10.1016/0035-9203(54)90006-1 Musso, 2016, Zika virus, Clin. Microbiol. Rev., 29, 487, 10.1128/CMR.00072-15 Odabasi, 2004, In vitro activity of anidulafungin against selected clinically important mold isolates, Antimicrob. Agents Chemother., 48, 1912, 10.1128/AAC.48.5.1912-1915.2004 Oehler, 2014, Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013, Euro Surveill., 19, 10.2807/1560-7917.ES2014.19.9.20720 Paixao, 2018, Zika, chikungunya and dengue: the causes and threats of new and re-emerging arboviral diseases, BMJ Glob Health, 3, 10.1136/bmjgh-2017-000530 Pfaller, 2005, In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole, J. Clin. Microbiol., 43, 5425, 10.1128/JCM.43.11.5425-5427.2005 Pilmis, 2015, Antifungal drugs during pregnancy: an updated review, J. Antimicrob. Chemother., 70, 14, 10.1093/jac/dku355 Schneidman-Duhovny, 2005, PatchDock and SymmDock: servers for rigid and symmetric docking, Nucleic Acids Res., 33, W363, 10.1093/nar/gki481 Shyr, 2021, Drug combination therapy for emerging viral diseases, Drug Discov. Today, 10.1016/j.drudis.2021.05.008 Song, 2017, Zika virus: history, epidemiology, transmission, and clinical presentation, J. Neuroimmunol., 308, 50, 10.1016/j.jneuroim.2017.03.001 Vergoten, 2021, In silico analysis of echinocandins binding to the main proteases of coronaviruses PEDV (3CL(pro)) and SARS-CoV-2 (M(pro)), 9, 41 Xu, 2016, Detection of Zika virus by SYBR green one-step real-time RT-PCR, J. Virol Methods, 236, 93, 10.1016/j.jviromet.2016.07.014